TrialDiabetologia2020

Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial.

Pieter F de Groot et al.PubMed ↗Publisher ↗

No numbers read from the abstract.